Skip to main content

Table 4 Medication taken by patients with non-coronary chest pain (NCCP) and population controls after 6 years follow-up according to the postal survey distributed in 2005

From: Non-coronary chest pain does not affect long-term mortality: a prospective, observational study using a matched population control

 

NCCP (n = 279) (%)

Controls (n = 530) (%)

p-value

ACE inhibitors

8.6

5.7

0.111

AII inhibitors

6.8

4.3

0.132

β-Blockers

27

16

<0.001

Ca2+-Blockers

8.6

6.6

0.299

Furosemide

6.5

6.0

0.816

Thiazides

15

8.5

0.004

Aspirin

18

11

0.013

Long-acting nitrates

4.7

1.1

0.002

Statins

13

9.2

0.078

Agents for acid-related disordersa

13

2.8

<0.001

Analgesics and NSAID

7.9

5.5

0.179

Anti-diabetic medication

4.7

4.2

0.735

COPD agents

7.5

3.6

0.014

Anti-depressants

7.9

6.0

0.317

Hypnotics and sedatives

10

8.1

0.358

  1. ACE angiotensin-converting enzyme, A II angiotensin II, NSAID non-steroidal anti-inflammatory drugs, COPD chronic obstructive pulmonary disease
  2. aAntacids, H2-receptor antagonists and proton pump inhibitors